Tony Mok

When the democracy movement in HK actually involves senseless violence against the one who speaks against it, they put shame on the good name of democracy

Thanks to JCO for their extra hard work allowing this simultaneous publication to be possible

With ARCHER1050 we have proved that more potent EGFR inhibition may attain longer PFS and OS but at the price of higher toxicity. Tough choice!

Looking at the PDL1<1%/TC0 subgroup data of KN407, CM227 and IMpowere131, I seriously doubt if this group of pts with SCC should receive chemo+IO. TMB is the way to go for selecting Nivo/ipi in this group

Keynote 158 on SCLC surprised me a bit. RR in the PDL1positive subgroup (n=42) was 35.7% and result is durable. Looking forward to the phase 3